These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8695995)

  • 21. Effect of neutropenia and granulocyte colony stimulating factor-induced neutrophilia on blood-brain barrier permeability and brain edema after traumatic brain injury in rats.
    Whalen MJ; Carlos TM; Wisniewski SR; Clark RS; Mellick JA; Marion DW; Kochanek PM
    Crit Care Med; 2000 Nov; 28(11):3710-7. PubMed ID: 11098978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient leukocytosis, granulocyte colony-stimulating factor plasma concentrations, and apoptosis determined by binding of annexin V by peripheral leukocytes in patients with severe sepsis.
    Weiss M; Elsharkawi M; Welt K; Schneider EM
    Ann N Y Acad Sci; 2003 Dec; 1010():742-7. PubMed ID: 15033821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized pilot trial of administration of granulocyte colony-stimulating factor to women before preterm delivery.
    Calhoun DA; Christensen RD
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):766-71. PubMed ID: 9757987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of granulocyte colony-stimulating factor on the incidence of threshold retinopathy of prematurity.
    Bhola R; Purkiss T; Hunter S; Stewart D; Rychwalski PJ
    J AAPOS; 2009 Oct; 13(5):450-3. PubMed ID: 19840722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns.
    Coşkun M; Kardelen F; Oygür N; Undar L; Savaş A; Yeğin O
    Turk J Pediatr; 1997; 39(3):295-301. PubMed ID: 9339107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte Colony-stimulating Factor for Preterms with Sepsis and Neutropenia: A Randomized Controlled Trial.
    Chaudhuri J; Mitra S; Mukhopadhyay D; Chakraborty S; Chatterjee S
    J Clin Neonatol; 2012 Oct; 1(4):202-6. PubMed ID: 24027727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
    Carr R; Brocklehurst P; Doré CJ; Modi N
    Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte-colony stimulating factor levels in cord blood and neonatal peripheral blood.
    Nakayama H; Kukita J; Ohga S; Ueda K
    Acta Paediatr Jpn; 1995 Apr; 37(2):237-9. PubMed ID: 7540793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, double-blinded, placebo-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to non-neutropenic preterm newborns between 33 and 36 weeks with presumed sepsis.
    Kücüködük S; Sezer T; Yildiran A; Albayrak D
    Scand J Infect Dis; 2002; 34(12):893-7. PubMed ID: 12587621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of granulocyte colony-stimulating factor on preeclampsia-associated neonatal neutropenia.
    La Gamma EF; Alpan O; Kocherlakota P
    J Pediatr; 1995 Mar; 126(3):457-9. PubMed ID: 7532709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
    Roberts RL; Szelc CM; Scates SM; Boyd MT; Soderstrom KM; Davis MW; Glaspy JA
    Am J Dis Child; 1991 Jul; 145(7):808-12. PubMed ID: 1711773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery.
    Bailie KE; Irvine AE; Bridges JM; McClure BG
    Pediatr Res; 1994 Feb; 35(2):164-8. PubMed ID: 7513077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor.
    Calhoun DA; Lunøe M; Du Y; Hutson AD; Veerman M; Christensen RD
    Pediatrics; 2000 Feb; 105(2):392-7. PubMed ID: 10654961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates.
    Kennon C; Overturf G; Bessman S; Sierra E; Smith KJ; Brann B
    J Pediatr; 1996 Jun; 128(6):765-9. PubMed ID: 8648534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-onset neutropenia in very low birth weight infants.
    Omar SA; Salhadar A; Wooliever DE; Alsgaard PK
    Pediatrics; 2000 Oct; 106(4):E55. PubMed ID: 11015550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancer.
    Arnedos M; Sutherland S; Ashley S; Smith I
    Breast Cancer Res Treat; 2008 Nov; 112(1):1-4. PubMed ID: 18060493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.